Twelve-Month Outcomes of iStent Infinite in Severe Open-Angle Glaucoma Compared with iStent Inject W in Mild-to-Moderate Disease
Journal of Clinical Medicine · 19.08.2026 · 15 (16) · 6396
DOI: 10.3390/jcm15166396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.08.2026. Verfasst von Sangwon Han und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju 26426, Gangwon-do, Republic of Korea. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The efficacy of two-stent implantation with iStent inject W is well established for mild-to-moderate open-angle glaucoma (OAG), whereas evidence for three-stent implantation with iStent infinite in severe OAG remains limited. We compared 12-month outcomes of a severity-based surgical strategy, using two stents in mild-to-moderate OAG and three stents in severe OAG.
Methods
This retrospective study included 100 eyes with OAG that were followed for at least 12 months after trabecular micro-bypass stent implantation. Eyes with mild-to-moderate disease, defined as visual field mean deviation (MD) of −12 dB or better, received two stents (iStent inject W), whereas eyes with severe disease, defined as MD worse than −12 dB, received three stents (iStent infinite). Outcomes included intraocular pressure (IOP), glaucoma medication burden, visual field parameters, corneal endothelial cell density (ECD), surgical success, and additional glaucoma surgery.
Results
Baseline IOP and the number of glaucoma medications were higher in the three-stent group. At 12 months, mean IOP was similar between groups. Although the three-stent group showed a greater unadjusted reduction in IOP, this difference was not significant after adjustment for baseline IOP using analysis of covariance. Linear mixed-model analysis also showed no significant group effect or time-by-group interaction. Glaucoma medications decreased significantly in both groups, with a similar mean reduction, although the three-stent group had a greater medication burden at 12 months. Changes in visual field parameters and corneal ECD did not differ significantly between groups. Surgical success and the need for additional glaucoma surgery were also not significantly different between groups.
Conclusions
In this retrospective cohort, three-stent implantation in severe OAG was associated with 12-month IOP outcomes similar to those observed in the two-stent group with mild-to-moderate OAG, although this was achieved with a greater residual medication burden. This approach appears feasible for patients with severe OAG.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju 26426, Gangwon-do, Republic of Korea.
ORCID-Profile: Sangwon Han, Sun Woong Kim
Zitieren
APA
Han, S., & Kim, S. W. (2026). Twelve-Month Outcomes of iStent Infinite in Severe Open-Angle Glaucoma Compared with iStent Inject W in Mild-to-Moderate Disease. Journal of Clinical Medicine, 15(16), 6396. https://doi.org/10.3390/jcm15166396
Vancouver
Han S, Kim SW. Twelve-Month Outcomes of iStent Infinite in Severe Open-Angle Glaucoma Compared with iStent Inject W in Mild-to-Moderate Disease. Journal of Clinical Medicine. 2026;15(16):6396. doi:10.3390/jcm15166396
BibTeX
@article{Han2026,
author = {Han, Sangwon and Kim, Sun Woong},
title = {Twelve-Month Outcomes of iStent Infinite in Severe Open-Angle Glaucoma Compared with iStent Inject W in Mild-to-Moderate Disease},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {16},
pages = {6396},
doi = {10.3390/jcm15166396}
}
EUVIMED